Comparison of the efficacy of inhaled fluticasone propionate, 880 μg/day, with flunisolide, 1500 μg/day, in moderate-to-severe persistent asthma

Annals of Allergy, Asthma and Immunology

Volumn 83, Issue 4, 1999, Pages 300-304

  Sheikh, Shahid ^a,c   Goldsmith, Linda J ^b   Howell, Laura ^a   Eid, Nemr ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUNISOLIDE; FLUTICASONE PROPIONATE; PREDNISONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE DERIVATIVE;

ABSENTEEISM; ADOLESCENT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; EMERGENCY HEALTH SERVICE; FEMALE; HOSPITAL ADMISSION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENCE RISK; SCHOOL CHILD; STEROID THERAPY;

EID: 0032697588     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62669-5     Document Type: Article

References (32)

1. National Asthma Education and Prevention Program, Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. National Institute of Health Publication No. 97-4051A, p. 29. May 1997.
2. Barnes PJ. Anti-inflammatory therapy for asthma. Annu Rev Med 1993;44: 229-42.
3. Barnes PJ, Pederson S. Efficacy and safety of inhaled corticosteroids in asthma: Am Rev Respir Dis 1993;148: S1-S26.
4. Barnes PJ. A new approach to the treatment of asthma. N Engl J Med 1989;321:1517-27.
5. Guidelines for the diagnosis and management of asthma: National Heart, Lung and Blood Institute, National Asthma Education Program Expert Panel Report. J Allergy Clin Immunol 1991;88:Suppl:425-534.
6. International Asthma Management Project. International Consensus report on the diagnosis and management of asthma. Clin Exp Allergy 1992;22: Suppl 1:1-72.
7. Guidelines on the management of asthma. Thorax 1997;52:Suppl: S1-S21.
8. Gustafsson P, Tsanakas J, Gold M, et al. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 μg/day with inhaled beclomethasone dipropionate 400 μg/ day in mild and moderate asthma. Arch Dis Child 1993;69:206-211.
9. Barnes NC, Marone G, Di Maria GU, et al. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate 2 mg daily, in the treatment of severe asthma. Eur Respir J 1993;6:877-884.
10. Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993;48: 817-823.
11. Bootsma GP, Dekhuijzen PNR, Festen J, et al. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Am J Crit Care Med 1996;153: 924-930.
12. Lundback B, Alexander M, Day J, et al. Evaluation of fluticasone propionate (500 μg/day) administered either as dry powder via a diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg/day) administered by pressurized inhaler. Respir Med 1993;87: 609-620.
13. Pauwels RA, Yernault JC, Demedts MG, Geusens P. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Am J Crit Care Med 1998;157:827-832.
14. Price JF, Weller PH. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open label group study). Respir Med 1995;89:363-368.
15. Price JF, Russell G, Hindmarsh PC, et al. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatr Pulmonol 1997;24: 178-186.
16. Edmunds AT, Goldberg RS, Duper B, et al. A comparison of budesonide 800 micrograms and 400 micrograms via Turbohaler with disodium cromoglycate via spinhaler for asthma prophylaxis in children. Br J Clin Res 1994; 5:11-23.
17. Gonzalez Perez-Yarza E, Garmendia Iglesisas A, Mintegui Aramburu J, et al. Prolonged treatment of mild asthma with inhaled anti-inflammatory therapy. Ann Esp Pediatr 1994;41: 102-106.
18. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92:64-77.
19. Meltzer EO, Orgel HA, Ellis EF, et al. Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma. J Allergy Clin Immunol 1992;90:2-11.
20. Youngchaiyud P, Permpikul C, Suthamsmai T, Wong E. A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma. Allergy 1995;50:28-33.
21. Verberne AA, Frost C, Bogaard JM, Kerrebijn KF. One year treatment with salmeterol compared to inhaled corticosteroid in children with mild to moderate asthma [Abstract]. Am J Respir Crit Care Med 1996;153:A408.
22. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
23. Greening AP, Ind PW, Northfield M, Shaw G. Treatment of adult asthmatic patients symptomatic on low dose inhaled corticosteroids: a comparison of the addition of salmeterol to existing inhaled corticosteroid therapy, with increasing the dose of inhaled corticosteroids. Lancet 1994;344:219-224.
24. Boyd G, UK study group. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. Eur Respir J 1995;8:1494-1498.
25. Nassif EG, Weinberger M, Thompson R, Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med 1981;304: 71-75.
26. Brenner M, Berkowitz R, Marshall N, Strunk RC. Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy 1988;18:143-150.
27. Rivington RN, Boulet LP, Cote J, et al. Efficacy of slow-release theophylline, inhaled salbutamol and their combination in asthmatic patients on high dose inhaled steroids. Am J Respir Crit Care Med 1995;151:325-332.
28. Kidney J, Dominguez M, Taylor PM, et al. Immunomodulation by theophylline in asthma: demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995;151:1907-1914.
29. Phillips GH. Structure-activity relationship of topically active steroids: the selection of fluticasone propionate. Respir Med 1990;84(Suppl A):19-23.
30. Brattsand R, Axelsson B. New inhaled glucocorticoids. In: Barnes PJ, ed. New drugs for asthma. Vol. 2. London: IBC Technical Services Ltd., 1992; 192-207.
31. Chaplin MD, Rooks W, Svenson EW, et al. Flunisolide metabolism and dynamics of a metabolite. Clin Pharmacol Ther 1980;27:402-413.
32. Harding SM. The human pharmacology of fluticasone dipropionate. Respir Med 1990;84(Suppl A):25-29.